These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27206263)

  • 61. [Off-label use of intravitreal bevacizumab for severe retinopathy of prematurity].
    Alba LE; Zaldua RA; Masini RA
    Arch Soc Esp Oftalmol; 2015 Feb; 90(2):81-6. PubMed ID: 25459682
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Primary intravitreal ranibizumab for high-risk retinopathy of prematurity.
    Baumal CR; Goldberg RA; Fein JG
    Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):432-8. PubMed ID: 25970863
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Long-term effects of anti-VEGF therapy for retinopathy of prematurity].
    Krohne TU; Müller A; Larsen PP; Holz FG
    Ophthalmologe; 2018 Jun; 115(6):464-468. PubMed ID: 29654389
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan.
    Wu WC; Kuo HK; Yeh PT; Yang CM; Lai CC; Chen SN
    Am J Ophthalmol; 2013 Jan; 155(1):150-158.e1. PubMed ID: 22967867
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].
    Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I
    Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antivascular endothelial growth factor for retinopathy of prematurity.
    Mintz-Hittner HA; Best LM
    Curr Opin Pediatr; 2009 Apr; 21(2):182-7. PubMed ID: 19300261
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anatomical and refractive outcomes in patients with treated retinopathy of prematurity.
    Lolas M; Tuma A; Zanolli M; Agurto R; Stevenson R; Ossandón D
    Arch Soc Esp Oftalmol; 2017 Oct; 92(10):472-476. PubMed ID: 28624314
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity.
    Morin J; Luu TM; Superstein R; Ospina LH; Lefebvre F; Simard MN; Shah V; Shah PS; Kelly EN;
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 27244705
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of adverse events between intravitreal anti-VEGF and laser photocoagulation for treatment-requiring retinopathy of prematurity: a systematic review.
    Tsiropoulos GN; Seliniotaki AK; Haidich AB; Ziakas N; Mataftsi A
    Int Ophthalmol; 2023 Mar; 43(3):1027-1062. PubMed ID: 36214992
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of Prematurity.
    Toy BC; Schachar IH; Tan GS; Moshfeghi DM
    Ophthalmology; 2016 Oct; 123(10):2166-75. PubMed ID: 27506484
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prediction of visual outcomes by an artificial neural network following intravitreal injection and laser therapy for retinopathy of prematurity.
    Huang CY; Kuo RJ; Li CH; Ting DS; Kang EY; Lai CC; Tseng HJ; Yang LY; Wu WC
    Br J Ophthalmol; 2020 Sep; 104(9):1277-1282. PubMed ID: 31744795
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of Plasma Cytokine Profile Changes in Bevacizumab-Treated Retinopathy of Prematurity Infants.
    Kong L; Demny AB; Sajjad A; Bhatt AR; Devaraj S
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1649-54. PubMed ID: 27054517
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bevacizumab versus diode laser in stage 3 posterior retinopathy of prematurity.
    Moran S; O'Keefe M; Hartnett C; Lanigan B; Murphy J; Donoghue V
    Acta Ophthalmol; 2014 Sep; 92(6):e496-7. PubMed ID: 24428792
    [No Abstract]   [Full Text] [Related]  

  • 74. Aqueous cytokine levels associated with severity of type 1 retinopathy of prematurity and treatment response to ranibizumab.
    Lyu J; Zhang Q; Jin H; Xu Y; Chen C; Ji X; Zhang X; Rao Y; Zhao P
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1469-1477. PubMed ID: 29948178
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Laser treatment or intravitreal VEGF inhibition for aggressive posterior retinopathy of prematurity?].
    Barth T; Hufendiek K; Helbig H; Oberacher-Velten I
    Ophthalmologe; 2015 Jun; 112(6):520-4. PubMed ID: 25573085
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society.
    Gangwe A; Agrawal D; Vinekar A; Azad RV; Parchand SM; Agrawal D
    Indian J Ophthalmol; 2021 Aug; 69(8):2158-2163. PubMed ID: 34304201
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Retinopathy of Prematurity: Evolving Treatment With Anti-Vascular Endothelial Growth Factor.
    Hartnett ME
    Am J Ophthalmol; 2020 Oct; 218():208-213. PubMed ID: 32450064
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Atypical case of retinopathy of prematurity with candle wax-like preretinal deposits and its surprising response to intravitreal antivascular endothelial growth factor.
    Shah MS; Padhy SK; Sahu S; Padhi TR
    BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35039342
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity.
    Hong GJ; Stinnett SS; Freedman SF; Wallace DK; Prakalapakorn SG
    J AAPOS; 2021 Jun; 25(3):177-180. PubMed ID: 33964453
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aggressive posterior retinopathy of prematurity in two cohorts of patients in South India: implications for primary, secondary, and tertiary prevention.
    Shah PK; Subramanian P; Venkatapathy N; Chan RVP; Chiang MF; Campbell JP
    J AAPOS; 2019 Oct; 23(5):264.e1-264.e4. PubMed ID: 31521847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.